# FlowTriever Pulmonary Embolectomy Clinical Study

Study · id `cardio:ct-nct02692586` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02692586](<https://clinicaltrials.gov/study/NCT02692586>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02692586

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

## Technical summary

Registry record NCT02692586. Allocation not applicable; no masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2017-11 (actual). Results posted on 2021-04-29.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 106 participants (enrolled count; ClinicalTrials.gov record NCT02692586, source copy `cardio:ctgov-nct02692586-2021-05-24`, retrieved 2026-10-31)
- Start date: 2016-04 (registry gives no type) (ClinicalTrials.gov record NCT02692586, source copy `cardio:ctgov-nct02692586-2021-05-24`, retrieved 2026-10-31)
- Primary completion: 2017-11 (actual) (ClinicalTrials.gov record NCT02692586, source copy `cardio:ctgov-nct02692586-2021-05-24`, retrieved 2026-10-31)
- Completion: 2017-11 (actual) (ClinicalTrials.gov record NCT02692586, source copy `cardio:ctgov-nct02692586-2021-05-24`, retrieved 2026-10-31)
- Results first posted: 2021-04-29 (ClinicalTrials.gov record NCT02692586, source copy `cardio:ctgov-nct02692586-2021-05-24`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT02692586, source copy `cardio:ctgov-nct02692586-2021-05-24`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02692586-2021-05-24`, retrieved 2026-10-31)

## The registry's words

- Brief title: FlowTriever Pulmonary Embolectomy Clinical Study
- Acronym: FLARE
- Condition: Pulmonary Embolism
- Condition: Acute Pulmonary Embolism
- Condition: Submassive Pulmonary Embolism
- Condition: Massive Pulmonary Embolism
- Intervention (Device): FlowTriever System
- Lead sponsor: Inari Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Inari Medical (`cardio:org-inari-medical`)

## Provenance

Content hash: 85fefdaf8232594c3f12df0e598b40e88cb5690a5cac9b02cea029de0160cb75
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
